Cargando…
A plasma SNORD33 signature predicts platinum benefit in metastatic triple-negative breast cancer patients
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764855/ https://www.ncbi.nlm.nih.gov/pubmed/35042534 http://dx.doi.org/10.1186/s12943-022-01504-0 |
| _version_ | 1784634248174501888 |
|---|---|
| author | Wang, Biyun Zhao, Yannan Li, Yi Xu, Yingying Chen, Yun Jiang, Qiuyu Yao, Dingjin Zhang, Li Hu, Xichun Fu, Chaowei Zhang, Si Chen, She |
| author_facet | Wang, Biyun Zhao, Yannan Li, Yi Xu, Yingying Chen, Yun Jiang, Qiuyu Yao, Dingjin Zhang, Li Hu, Xichun Fu, Chaowei Zhang, Si Chen, She |
| author_sort | Wang, Biyun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8764855 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87648552022-01-19 A plasma SNORD33 signature predicts platinum benefit in metastatic triple-negative breast cancer patients Wang, Biyun Zhao, Yannan Li, Yi Xu, Yingying Chen, Yun Jiang, Qiuyu Yao, Dingjin Zhang, Li Hu, Xichun Fu, Chaowei Zhang, Si Chen, She Mol Cancer Letter to the Editor BioMed Central 2022-01-18 /pmc/articles/PMC8764855/ /pubmed/35042534 http://dx.doi.org/10.1186/s12943-022-01504-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Letter to the Editor Wang, Biyun Zhao, Yannan Li, Yi Xu, Yingying Chen, Yun Jiang, Qiuyu Yao, Dingjin Zhang, Li Hu, Xichun Fu, Chaowei Zhang, Si Chen, She A plasma SNORD33 signature predicts platinum benefit in metastatic triple-negative breast cancer patients |
| title | A plasma SNORD33 signature predicts platinum benefit in metastatic triple-negative breast cancer patients |
| title_full | A plasma SNORD33 signature predicts platinum benefit in metastatic triple-negative breast cancer patients |
| title_fullStr | A plasma SNORD33 signature predicts platinum benefit in metastatic triple-negative breast cancer patients |
| title_full_unstemmed | A plasma SNORD33 signature predicts platinum benefit in metastatic triple-negative breast cancer patients |
| title_short | A plasma SNORD33 signature predicts platinum benefit in metastatic triple-negative breast cancer patients |
| title_sort | plasma snord33 signature predicts platinum benefit in metastatic triple-negative breast cancer patients |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764855/ https://www.ncbi.nlm.nih.gov/pubmed/35042534 http://dx.doi.org/10.1186/s12943-022-01504-0 |
| work_keys_str_mv | AT wangbiyun aplasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT zhaoyannan aplasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT liyi aplasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT xuyingying aplasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT chenyun aplasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT jiangqiuyu aplasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT yaodingjin aplasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT zhangli aplasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT huxichun aplasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT fuchaowei aplasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT zhangsi aplasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT chenshe aplasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT wangbiyun plasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT zhaoyannan plasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT liyi plasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT xuyingying plasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT chenyun plasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT jiangqiuyu plasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT yaodingjin plasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT zhangli plasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT huxichun plasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT fuchaowei plasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT zhangsi plasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients AT chenshe plasmasnord33signaturepredictsplatinumbenefitinmetastatictriplenegativebreastcancerpatients |